13F
← All fund report cards

Roundview Capital LLC

13F equity value
$1.6B
Positions
340
Top 10 concentration
31.6%
Quarters / total new picks
32 / 337
13F equity value over time
$0M$813M$2B2017201820192020202120222023202420252026

"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.

Not significant Verdict

13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.

We backtested copying it anyway. Buying this fund's new positions the day each filing went public, over 32 quarters, returned +1.9% per quarter — versus +2.7% per quarter from simply owning every 13F stock. It beat that baseline in only 43.8% of quarters (excess t = 0.06, not statistically significant). Its filings tell you what it bought — not what you should buy.

Avg 2Q excess
+0.1%
t-stat
0.06
Quarterly win rate
44%
Annualized excess
-3.3%
$1 → follow vs universe
$1.63 vs $2.09
Cumulative return: $1 invested in new picks vs universe
1.00 20180331: universe 1.04120180630: universe 0.95920180930: universe 1.00320181231: universe 0.99220190331: universe 0.97520190630: universe 1.04820190930: universe 1.12720191231: universe 0.90920200331: universe 1.09620200630: universe 1.21120200930: universe 1.48520201231: universe 1.55320210331: universe 1.56620210630: universe 1.69220210930: universe 1.51920211231: universe 1.29220220331: universe 1.38720220630: universe 1.28520220930: universe 1.38120221231: universe 1.28220230331: universe 1.35120230630: universe 1.30320230930: universe 1.47920231231: universe 1.54520240331: universe 1.58020240630: universe 1.72320240930: universe 1.70820241231: universe 1.59420250331: universe 1.73820250630: universe 1.79320250930: universe 2.01620251231: universe 2.085 20180331: follow 1.09320180630: follow 1.08020180930: follow 1.01920181231: follow 1.03020190331: follow 1.05820190630: follow 1.13120190930: follow 1.17920191231: follow 1.01320200331: follow 1.14620200630: follow 1.22720200930: follow 1.38220201231: follow 1.48320210331: follow 1.53520210630: follow 1.60020210930: follow 1.47320211231: follow 1.24020220331: follow 1.24120220630: follow 1.06920220930: follow 1.23120221231: follow 1.18820230331: follow 1.24220230630: follow 1.20020230930: follow 1.37020231231: follow 1.38320240331: follow 1.36920240630: follow 1.41920240930: follow 1.39520241231: follow 1.49520250331: follow 1.42720250630: follow 1.32620250930: follow 1.44120251231: follow 1.634 0.84 1.54 2.25 20182019202020212022202320242025 Follow Universe

Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)

Listed as facts. See the verdict above before treating this as signal.

Top 20 holdings of 340 · 2026 Q1

Ticker Value Weight QoQ
AAPL $73M
4.6%
HOLD
GOOG $72M
4.5%
HOLD
BRK/B $63M
3.9%
TRIM
VOO $59M
3.7%
HOLD
MSFT $57M
3.5%
ADD
AMZN $44M
2.8%
HOLD
SCHB $42M
2.6%
HOLD
VTI $35M
2.2%
HOLD
QQQ $33M
2.1%
HOLD
VGIT $30M
1.9%
HOLD
NVDA $29M
1.8%
HOLD
BIV $29M
1.8%
ADD
TSM $26M
1.6%
HOLD
META $22M
1.4%
HOLD
MA $20M
1.2%
TRIM
V $18M
1.1%
ADD
JPM $18M
1.1%
HOLD
COST $18M
1.1%
HOLD
BIL $18M
1.1%
TRIM
BND $18M
1.1%
ADD

QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.

Listed as facts. See the verdict above before treating this as signal.

New positions in 2026 Q1

Method & Limitations

Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.